I agree that this site is using cookies. You can find further informations here.
X
Dupre, Tess V.
8  results:
OpenAccess-fulltext X
Search for persons X
?
1

Neutral ceramidase deficiency protects against cisplatin-in..:

Sears, Sophia M ; Dupre, Tess V ; Shah, Parag P...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953688/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
2

Moderate aging does not exacerbate cisplatin-induced kidney..:

Sharp, Cierra N ; Doll, Mark ; Dupre, Tess V..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6383196/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
3

Inhibiting glucosylceramide synthase exacerbates cisplatin-..:

Dupre, Tess V ; Doll, Mark A ; Shah, Parag P...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496040/.  , 2017
Link: http://www.ncbi.nlm.nih...
 
?
4

Repeated administration of low-dose cisplatin in mice induc..:

Sharp, Cierra N ; Doll, Mark A ; Dupre, Tess V...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4796272/.  , 2016
Link: http://www.ncbi.nlm.nih...
 
?
5

Suramin protects from cisplatin-induced acute kidney injury:

Dupre, Tess V ; Doll, Mark A ; Shah, Parag P...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877945/.  , 2015
Link: http://www.ncbi.nlm.nih...
 
?
6

Targeting of BRAF resistant melanoma via extracellular matr..:

Zeiderman, Matthew R ; Egger, Michael E ; Kimbrough, Charles W...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4576881/.  , 2014
Link: http://www.ncbi.nlm.nih...
 
?
7

Neutral ceramidase deficiency protects against cisplatin-in..:

Sophia M. Sears ; Tess V. Dupre ; Parag P. Shah...
http://www.sciencedirect.com/science/article/pii/S0022227522000128.  , 2022
Link: https://doi.org/10.1016/..
 
?
8

Inhibiting glucosylceramide synthase exacerbates cisplatin-..:

Tess V. Dupre ; Mark A. Doll ; Parag P. Shah...
http://www.sciencedirect.com/science/article/pii/S0022227520335938.  , 2017
Link: https://doi.org/10.1194/..
 
1-8